Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07592533 · ClinicalTrials.gov registry record · NA
A Single Arm Study of Extracorporeal Shockwave Therapy for Management of Erectile Dysfunction
A NA study, sponsored by University of California, San Francisco.
- Recruiting
- Registry status
- NA
- Development phase
- 157
- Enrollment target
NCT07592533 is a NA study that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 157 participants.
The verdict
NCT07592533, a NA study, is actively recruiting participants, sponsored by University of California, San Francisco.
- RECRUITING
- Registry status
- NA
- Development phase
- 157 participants
- Enrollment target
Study Summary
This is a device study (while the device has been patented and cleared by the FDA, the indication of the use for Erectile Dysfunction has been yet approve). EXSTACY is a study to collect information on which patients who have trouble getting or keeping an erection rigid enough for sex (sometimes known as Erectile Dysfunction or ED) benefit from light intensity shockwave therapy (LI-SWT). LI-SWT is a form of energy transfer to the penis that has been shown to help some men with ED in studies over the past decade. This study will collect information about patients prior to treatment to determine what predicts a good outcome. The investigators hope that this information will help decide which patients are likely to benefit from LI-SWT and which patients should consider other treatments for ED.
Interventions
- DEVICE Shockwave therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 157 participants |
| Start Date | 2024-09-10 |
| Est. Completion | 2027-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07592533
The ClinicalTrials.gov registry entry for NCT07592533 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 157 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Shockwave therapy is the first listed.
NCT07592533 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07592533 about?
NCT07592533 is a clinical study titled "A Single Arm Study of Extracorporeal Shockwave Therapy for Management of Erectile Dysfunction". This is a device study (while the device has been patented and cleared by the FDA, the indication of the use for Erectile Dysfunction has been yet approve). EXSTACY is a study to collect information on which patients who have trouble getting or keeping an erection rigid enough for sex (sometimes kno...
What is the current status of trial NCT07592533?
This trial is currently recruiting. It is a NA study. The enrollment target is 157 participants. The study started on 2024-09-10. Estimated completion is 2027-12-31.
What interventions are being tested in trial NCT07592533?
The interventions under investigation include: Shockwave therapy (DEVICE).
Who is sponsoring clinical trial NCT07592533?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.